Clinical Trial Update: Inaticabtagene Autoleucel Injection in the Treatment of Autoimmune Hemolytic Anemia After Three or More Lines of Therapy [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating Inaticabtagene Autoleucel for autoimmune hemolytic anemia after three or more prior therapies; the study status is not yet r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Hemolytic Anemia

Drugs mentioned

• Inaticabtagene Autoleucel

Snippet

Sponsor: Juventas Cell Therapy Ltd. | Conditions: AIHA - Cold Autoimmune Hemolytic Anemia | Phase 1 | Status: NOT_YET_RECRUITING